Empower Advisory Group’s AbbVie ABBV Stock Holding History

Empower Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$112M	Buy	514,594 +31,987	+7%	+$7.1M	0.29%	71
2025 Q4	$110M	Sell	482,607 -21,661	-4%	-$4.93M	0.3%	64
2025 Q3	$117M	Buy	504,268 +7,835	+2%	+$1.6M	0.32%	59
2025 Q2	$92.1M	Buy	496,433 +22,390	+5%	+$4.16M	0.28%	71
2025 Q1	$99.3M	Buy	474,043 +26,384	+6%	+$5.13M	0.32%	57
2024 Q4	$79.5M	Buy	447,659 +12,415	+3%	+$2.28M	0.27%	74
2024 Q3	$86M	Sell	435,244 -163,171	-27%	-$30.5M	0.29%	74
2024 Q2	$103M	Sell	598,415 -9,270	-2%	-$1.54M	0.38%	57
2024 Q1	$111M	Buy	607,685 +12,613	+2%	+$2.17M	0.41%	50
2023 Q4	$92.2M	Buy	595,072 +19,856	+3%	+$2.89M	0.36%	64
2023 Q3	$85.7M	Buy	575,216 +52,198	+10%	+$7.66M	0.38%	53
2023 Q2	$70.5M	Buy	523,018 +38,914	+8%	+$5.71M	0.3%	73
2023 Q1	$77.7M	Buy	+484,104	New	+$74M	0.35%	66

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Empower Advisory Group's ABBV Position: Q1 2026 in Review

Empower Advisory Group increased its AbbVie (ABBV) stake by 6.6% in Q1 2026, buying an estimated $7.1M and bringing the position to 514,594 shares worth $112M. The position accounts for 0.29% of the portfolio, ranked #71.

Empower Advisory Group first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $117M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Empower Advisory Group held 514,594 shares of AbbVie worth $112M as of Q1 2026.
Empower Advisory Group bought 31,987 AbbVie shares in Q1 2026, an estimated $7.1M.
AbbVie made up 0.29% of Empower Advisory Group's portfolio in Q1 2026, its #71 holding.
Empower Advisory Group first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Empower Advisory Group's AbbVie position peaked at $117M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.